MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 230 filers reported holding MEDICINES CO in Q1 2017. The put-call ratio across all filers is 1.41 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $26,958,000 | -8.7% | 709,229 | +17.4% | 0.20% | -9.6% |
Q1 2017 | $29,537,000 | +245.6% | 604,020 | +139.9% | 0.22% | +230.3% |
Q4 2016 | $8,546,000 | +446.8% | 251,790 | +507.9% | 0.07% | +407.7% |
Q3 2016 | $1,563,000 | -8.0% | 41,419 | -18.0% | 0.01% | -7.1% |
Q2 2016 | $1,699,000 | -11.5% | 50,529 | -16.4% | 0.01% | -6.7% |
Q1 2016 | $1,920,000 | -82.1% | 60,424 | -78.9% | 0.02% | -83.1% |
Q4 2015 | $10,700,000 | -60.7% | 286,559 | -60.0% | 0.09% | -61.1% |
Q3 2015 | $27,206,000 | -24.3% | 716,712 | -43.0% | 0.23% | -11.2% |
Q2 2015 | $35,953,000 | -44.6% | 1,256,653 | -45.7% | 0.26% | -44.9% |
Q1 2015 | $64,864,000 | +76.4% | 2,314,908 | +74.2% | 0.47% | +72.7% |
Q4 2014 | $36,762,000 | +504.3% | 1,328,598 | +534.7% | 0.27% | +502.2% |
Q2 2014 | $6,083,000 | -85.6% | 209,341 | -85.9% | 0.04% | -85.2% |
Q1 2014 | $42,153,000 | -37.5% | 1,483,219 | -15.1% | 0.30% | -39.0% |
Q4 2013 | $67,466,000 | +137.5% | 1,746,929 | +106.1% | 0.50% | +128.3% |
Q3 2013 | $28,410,000 | – | 847,550 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |